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ABSTRACT X-ray structures are known for three members of the Major Facilitator Superfamily (MFS) of membrane transporter
proteins, thus enabling the use of homology modeling to extrapolate to other MFS members. However, before employing such
models for, e.g., mutational or docking studies, it is essential to develop a measure of their quality. To aid development of such
metrics, two disparate MFS members (NupG and GLUT1) have been modeled. In addition, control models were created with
shufﬂed sequences, to mimic poor quality homology models. These models and the template crystal structures have been
examined in termsof both static anddynamic indicators of structural quality. Comparison of the behavior ofmodeled structureswith
the crystal structures in molecular dynamics simulations provided a metric for model quality. Docking of the inhibitor forskolin to
GLUT1 and to a control model revealed signiﬁcant differences, indicating that we may identify accurate models despite low
sequence identity between target sequences and templates.
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The Major Facilitator Superfamily (MFS) is a large family
of membrane transporter proteins present in bacteria, archaea,
and eukarya (1). Sequence-based predictions indicate that a
12- or 14-transmembrane (TM) helix topology is shared by all
MFS members. MFSs transport a wide range of solutes by
diverse mechanisms (uniport, symport, and antiport). Prob-
lems associated with overexpression of membrane proteins
mean that only three distinct x-ray structures are available for
MFSs, namely: LacY (2); the glycerol-3-phosphate trans-
porter (GlpT) (3); and EmrD, a multi-drug transporter (4).
Despite relatively low sequence identities (;15%) be-
tween LacY, GlpT, and EmrD, all share a similar fold and
arrangement of TM helices. LacY and GlpT are resolved in
an inward-facing open conformation, allowing intracellular
access to the central binding site. EmrD is in a closed con-
formation (similar to that seen in the electron microscopy
images of OxlT (5)). These structures offer the possibility of
homology modeling of other MFSs (6,7), despite very low
sequence identities. However, it is important to assess the
quality of such models (8).
We have used a combined simulation and docking ap-
proach to assess MFS homologymodels. TwoMFSmembers
were modeled: GLUT1, a human facilitative glucose trans-
porter using GlpT as a template; and NupG (a bacterial
nucleoside transporter), using LacY as a template. Initial se-
quence alignments were adjustedmanually to optimize agree-
ment with experimental data.
In addition, two ‘‘control’’ models were created: LacY-
Con and GLUT1Con (Table 1). In these, the amino-acid se-
quences of LacY and GLUT1, respectively, were subject to
thorough pairwise shufﬂing (gaps in the GLUT1 alignment
were not subject to shufﬂing) immediately before homology
modeling (i.e., a shufﬂed alignment was used as the input to
modeling). Note that this approach leaves the amino-acid
composition of the GLUT1Con model the same as that of the
‘‘true’’ GLUT1 model.
Structures and models were also used as starting struc-
tures for 15-ns molecular dynamics (MD) simulations using
GROMACS (www.gromacs.org) in solvated dimyristoyl
phosphatidylcholine bilayers (system size ;65,000 atoms).
Repeat simulations of the GLUT1 and GLUT1Con models
were performed to provide an estimate of the variability in
conformational sampling between simulations. Docking of
the potent GLUT1 inhibitor forskolin (9) into the GLUT1 and
GLUT1Con models was performed using Autodock 3 (10).
Previous modeling studies (6) have used static indicators
of model stereochemical quality, e.g., Ramachandran anal-
ysis, reinforced by evaluation of the model against available
experimental data. The latter approach is clearly difﬁcult for
high throughput modeling a wide range of MFS proteins
(as is obtaining a high-quality sequence alignment). In this
study, we employ a metric for model quality based on dy-
namic behavior in simulations. Inclusion of the LacY and
GlpT crystal structures and the sequence-shufﬂed controls
enables us to evaluate dynamic indicators of model quality
for the GLUT1 and NupG models.
For multiple structures/models/simulations of the same
protein, analysis of Ramachandran plots of backbone dihe-
drals has proved useful (11). However, the percentage of
residues in the ‘‘Core 1 Allowed’’ regions (as deﬁned by
Procheck) of the Ramachandran plot is equally high for x-ray
structures, for the ‘‘true’’ models, and for the control models.
Thus, although a necessary criterion for a high quality
model, this measure is not sufﬁcient to discriminate between
good and poor models.
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A simple measure of the conformational stability of an
MFS fold is provided by the root mean-square deviation
(RMSD) of the Ca atoms of the core helical domains from
the corresponding starting structure, thus excluding the
ﬂexible termini and interdomain linker regions (Table 1). It is
evident that RMSDs for the crystal structures are lower than
for each of their respective models, as might be expected.
However, encouragingly the RMSDs of the models are
signiﬁcantly lower than that of both controls, indicating that
in even the relatively short timescales accessible to MD
simulations differential behavior can be observed. Further-
more, the repeat simulations yield similar RMSD values,
lending conﬁdence to our observations.
These differences in conformational stability are also appa-
rent in the end structures of the simulations (Fig. 1). The
structure of GlpT can be seen to have changed little during the
course of the simulation, and the structure of theGLUT1model
in the two simulations remains close to that of the template.
Interestingly, in both theGlpT andGLUT1 simulations there is
a degree of kinking of the C-terminal helix, enabling the
intracellular segment to interactwith the lipid headgroups. This
indicates that changes in MFS structure can occur on an;15-
ns timescale. In contrast, the GLUT1Con model exhibits
substantial helix loss, and dissociation of the two six TMhelix
domains. Indeed, loss of a-helicity in the two six TM helix
bundle domains is the clearest indicator of a difference in
structural stability (Table 1). Both control models show over
20% loss in a-helix content in their core domains, while the
crystal structures show only 7% and 4% for LacY and GlpT,
respectively. The models show a maximum loss of only 7%
for GLUT1 and as low as 2% for NupG. Such low levels,
comparable to the two crystal structures, lend conﬁdence to
the quality of these models. Taken together, these analyses
suggest that one may discriminate between good and poor
models of MFS proteins using dynamic structural properties
more readily than via static stereochemical analyses.
One use of homology models is in the study of protein/
inhibitor interactions. For example, a number of authors have
used docking to explore interactions of inhibitors with
GLUT1 models (6,12). We have docked the high afﬁnity
inhibitor forskolin to the GLUT1 and GLUT1Con models
(using Autodock3 (10)). Comparing ensembles of 1000 docks
(from the Lamarckian genetic algorithm) reveals a clear
difference in behavior between the two models (Fig. 2). For
GLUT1, the 1000 docks converge to only a few consistent
TABLE 1 Summary of models and simulations
Name
Sequence
identity (%)
Core 1
Allowed (%)
RMSD
(A˚)
a-Helix
loss (%)
LacY — 99 3.2 6 0.07 7 6 0.01
LacYCon 8 99 4.3 6 0.07 23 6 0.01
NupG 10 99 3.8 6 0.06 2 6 0.01
GlpT — 96 2.4 6 0.05 4 6 0.01
GLUT1 12 98 3.6 6 0.07 7 6 0.01
98 3.9 6 0.08 6 6 0.01
GLUT1Con 6 98 4.5 6 0.09 19 6 0.02
98 4.5 6 0.06 20 6 0.01
Sequence identity is with the template; Core 1 Allowed refers to the
percentage of residues in the corresponding region of the Ramachandran
plot. RMSDs are for core-domain Ca atoms relative to the corresponding
initial structures and are evaluated over the period 14–15 ns. The a-helix
loss is for core-domain residues. For GLUT1 and GLUT1Con, the second
set of ﬁgures refer to the repeat simulations.
FIGURE 2 Docking of forskolin (shown in bonds format in gray/
red/white) into the central cavity of models: (A) GLUT1; and (B)
GLUT1Con. Panel C shows the three lowest interaction energy
clusters for GLUT1 in purple, cyan, and yellow, respectively.
FIGURE 1 Initial (0 ns) and ﬁnal (15 ns) structures (helices in
orange, loops in blue/gray) from simulations: GlpT (A,E); GLUT1
(B,F); GLUT1Rep (C,G); and GLUT1Con (D,H). The phosphorus
atoms of the dimyristoyl phosphatidylcholine bilayer are shown
for the GlpT simulation as gray spheres.
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binding modes. The lowest energy docking mode (seen for
31% of docks) corresponds to a pocket formed by the
packing of TM helices 7, 10, and 11. Forskolin forms
H-bonds to Trp388, and its concatenated ring stacks on top of
Trp412. Both these residues have been implicated in forskolin
binding. Clusters 2 and 3 represent a different binding mode,
differing from each other only by a small translation. Inter-
actions in this mode are formed by TM helices 1, 4, and 5,
with few speciﬁc side chain interactions.
In marked contrast, the output of docking for GLUT1Con
failed to reveal a consistent binding mode. Instead, the 1000
docks simply ﬁlled the available volume of the central cav-
ity. Thus, for GLUT1 .90% of the 1000 docking attempts
were within the top two docking clusters. This contrasts with
only 56% for docking into GLUT1Con, increasing to only
66% if the top ﬁve clusters are considered. In total there are
eight docking clusters for GLUT1 and 42 for GLUT1Con.
This difference in docking behavior suggests that the envi-
ronment within the central cavity of the GLUT1 model is at
least a reasonable approximation to that of the true structure.
Taken together, our results indicate that ;10-ns MD sim-
ulations in a simple lipid bilayer environment can distinguish
the conformational stability of a crystal structure and a con-
trol model, or of a plausible homology model and a control
model. The latter is encouraging, given the low percentage
identity of the model and template sequences. Furthermore,
the conformational stability (measured in terms of Ca
RMSDs and especially in terms of loss of a-helicity of the
core fold) of the (plausible) models is comparable to that of
the x-ray structures and consistent between repeat simula-
tions. This degree of discrimination is possible despite all of
the starting models (‘‘true’’ and controls) having comparable
stereochemistry as judged by, e.g., Ramachandran plots.
These results have important consequences for attempts to
apply high throughput modeling (13) to transporters. There
are estimated to be .1000 members of the MFS (www.
tcdb.org) in 54 different families. Assuming accurate se-
quence alignments to be achievable, to generate a good ho-
mology model of each member would take ;1 h of cpu. To
run an ;10-ns simulation of a best homology model and a
decoy (i.e., control) for each member would require ;3000
cpu hours. This is not an unreasonable challenge.
In summary, it appears that combining homology mod-
eling with MD simulation can be used to extrapolate from a
few x-ray structures to a complete set of plausible homology
models, annotated with comparative metrics for their stabil-
ity. Such models may then be further evaluated by, e.g.,
cysteine-scanning mutagenesis (14). As x-ray structures of
further MFS members emerge, a more ﬁne-grained analysis
approach may be possible, e.g., comparing the conforma-
tional stability of a model of GlpT based on the structure of
EmrD. In this manner it will be possible to cautiously pro-
gress to high throughput modeling from all available structures.
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